These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26180022)
41. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways. Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376 [TBL] [Abstract][Full Text] [Related]
42. The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium. Monasky MM; Taglieri DM; Henze M; Warren CM; Utter MS; Soergel DG; Violin JD; Solaro RJ Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H856-66. PubMed ID: 23873795 [TBL] [Abstract][Full Text] [Related]
43. Biased Agonist TRV027 Determinants in AT1R by Molecular Dynamics Simulations. Modestia SM; Malta de Sá M; Auger E; Trossini GHG; Krieger JE; Rangel-Yagui CO J Chem Inf Model; 2019 Feb; 59(2):797-808. PubMed ID: 30668103 [TBL] [Abstract][Full Text] [Related]
44. Comparative evaluation of biased agonists Sarcosine Noto NM; Restrepo YM; Pang HW; Stoyell-Conti F; West CA; Speth RC Pharmacol Res Perspect; 2023 Feb; 11(1):e01053. PubMed ID: 36639940 [TBL] [Abstract][Full Text] [Related]
45. Troglitazone stimulates beta-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor. Tilley DG; Nguyen AD; Rockman HA Biochem Biophys Res Commun; 2010 Jun; 396(4):921-6. PubMed ID: 20460106 [TBL] [Abstract][Full Text] [Related]
46. Prolonged AT Hermosilla T; Encina M; Morales D; Moreno C; Conejeros C; Alfaro-Valdés HM; Lagos-Meza F; Simon F; Altier C; Varela D Sci Rep; 2017 Aug; 7(1):10131. PubMed ID: 28860469 [TBL] [Abstract][Full Text] [Related]
47. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells. Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619 [TBL] [Abstract][Full Text] [Related]
48. Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R. Lino CA; de Bortoli Teixeira L; Capelupe Simões S; de Oliveira Silva T; Diniz GP; da Costa-Neto CM; Barreto-Chaves MLM J Cell Physiol; 2021 Jun; 236(6):4640-4654. PubMed ID: 33345322 [TBL] [Abstract][Full Text] [Related]
49. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Pang PS; Butler J; Collins SP; Cotter G; Davison BA; Ezekowitz JA; Filippatos G; Levy PD; Metra M; Ponikowski P; Teerlink JR; Voors AA; Bharucha D; Goin K; Soergel DG; Felker GM Eur Heart J; 2017 Aug; 38(30):2364-2373. PubMed ID: 28459958 [TBL] [Abstract][Full Text] [Related]
51. β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility. Abraham DM; Davis RT; Warren CM; Mao L; Wolska BM; Solaro RJ; Rockman HA Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14426-14431. PubMed ID: 27911784 [TBL] [Abstract][Full Text] [Related]
52. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways. Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463 [TBL] [Abstract][Full Text] [Related]
53. The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor. Turu G; Balla A; Hunyady L Front Endocrinol (Lausanne); 2019; 10():519. PubMed ID: 31447777 [TBL] [Abstract][Full Text] [Related]
54. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Balakumar P; Jagadeesh G Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996 [TBL] [Abstract][Full Text] [Related]
55. beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Rakesh K; Yoo B; Kim IM; Salazar N; Kim KS; Rockman HA Sci Signal; 2010 Jun; 3(125):ra46. PubMed ID: 20530803 [TBL] [Abstract][Full Text] [Related]
56. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists. Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM Front Pharmacol; 2015; 6():131. PubMed ID: 26191004 [TBL] [Abstract][Full Text] [Related]
57. Functional relevance of biased signaling at the angiotensin II type 1 receptor. Tilley DG Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):99-111. PubMed ID: 21476968 [TBL] [Abstract][Full Text] [Related]
58. Low-dose angiotensin AT Esmaeeli A; Ebrahimi F; Tanha K; Assadi M; Seyedabadi M Pharmacol Rep; 2020 Dec; 72(6):1676-1684. PubMed ID: 33090352 [TBL] [Abstract][Full Text] [Related]
59. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses. Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993 [TBL] [Abstract][Full Text] [Related]
60. Interactions between AT1R and GRKs: the determinants for activation of signaling pathways involved in blood pressure regulation. Poonam ; Chaudhary S Mol Biol Rep; 2023 Dec; 51(1):46. PubMed ID: 38158508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]